No Data
No Data
CNS Pharmaceuticals Reports Q2 Results
Express News | CNS Pharmaceuticals Q2 EPS $(6.72) Up From $(51.86) YoY
Express News | CNS Pharmaceuticals Q2 2024 Net Loss Reduced To $2.5M Due To Lower CRO Expenses; R&D Costs Decrease To $1.1M; G&A Expenses Increase To $1.4M Due To Higher Legal And Professional Fees
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
CNS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
No Data
103539036 : Any good news?
Mike2828 OP : Secret surprice on monday![grin 😁](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f601.png)
![grin 😁](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f601.png)
![grin 😁](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f601.png)